Clinical Trial: 20341

Trial Status: Open
Disease Type: Colorectal
Trial ID 20341
Sponsor ID BESPOKE

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer (20-041-NCP)

Principal Investigator
Keeran R. Sampat, MD
3 Locations

Locations

Arlington Office

Fairfax Office

Gainesville Office

Learn More About This Trial

Other Relevant Trials
Trial ID GS-US-587-6156
Sponsor ID Gilead Sciences, Inc

A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (CRC)

Principal Investigator
Keeran R. Sampat, MD
3 Locations
Trial ID GO-010
Sponsor ID Gritstone

A Phase 2/3, Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer

1 Location